Financial Summary (All financials)
In millions, except per share items | Jan-31-22 | Jan-31-21 | Jan-31-20 | Jan-31-19 | Jan-31-18 | Jan-31-17 | Jan-31-16 | Jan-06-15 |
Revenues | -1.3 | -1.0 | -0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Revenue growth | 25.5% | 53.5% | | | | | | |
Cost of goods sold | -2.5 | -2.0 | -1.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 |
Gross profit | 1.3 | 1.0 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 |
Gross margin | -100.0% | -100.0% | -100.0% | | | | | |
Selling, general and administrative | 1.3 | 1.0 | 0.7 | 0.6 | 0.5 | 0.5 | 0.3 | 0.0 |
EBIT | -18.1 | 38.3 | 29.7 | -2.9 | 13.2 | 2.9 | -8.2 | 0.0 |
EBIT margin | 1422.5% | -3781.5% | -4505.0% | | | | | |
Pre-tax income | -16.9 | 39.3 | 30.4 | -2.3 | 13.7 | 3.5 | -7.9 | 0.0 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
Net income | -16.9 | 39.3 | 30.4 | -2.3 | 13.7 | 3.5 | -7.9 | 0.0 |
Net margin | 1330.3% | -3881.5% | -4605.0% | | | | | |
|
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|